Skip to the page

Data / Drug companies / Guangzhou Mizi Biotechnology Co., LTD.

Guangzhou Mizi Biotechnology Co., LTD.: 10 products in the FDA NDC directory, labeler code 84896

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Guangzhou Mizi Biotechnology Co., LTD. (labeler code 84896) lists 10 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 10 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on May 26, 2026.

The request: Watch Guangzhou Mizi Biotechnology Co., LTD. (FDA labeler code 84896): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84896
Products in commercial distribution
10
Packages
10
Finished drugs by generic name
4
Prescription products
0
Over the counter products
10
Flagged as original packager
10 of 10 products that carry the flag
Started marketing in the last 12 months
9
Earliest marketing start
September 16, 2025
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs10100%

Products by type

TypeProductsShare
Over the counter drugs10100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Undecylenic acid338
Angelica dahurica root11
Tea tree oil12
Angelica dahurica extractt, asiatic acid11

Dosage forms

Dosage formProductsShare
Liquid550%
Cream330%
Paste110%
Spray110%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Toenail Fungus Pen Preventative84896-010SprayOver the counter monograph drugsMay 26, 2026
Nail extra strength repair pen84896-009LiquidOver the counter monograph drugsMay 26, 2026
Antifungal pen84896-008LiquidOver the counter monograph drugsMay 26, 2026
Tattoo numbing cream84896-007CreamOver the counter monograph drugsMarch 12, 2026
BEE VENOM SKIN FIRMING Cream84896-006CreamOver the counter monograph drugsMarch 12, 2026
Stye eye relief serum84896-005LiquidOver the counter monograph drugsMarch 6, 2026
ANTIFUNGAL Cream84896-004CreamOver the counter monograph drugsMarch 6, 2026
NAIL TREATMENT Oil Elixirs84896-003LiquidOver the counter monograph drugsNovember 27, 2025
Liquid Wart Corn Callus Remover84896-002LiquidOver the counter monograph drugsNovember 27, 2025
Stye eye relief serum84896-001PasteOver the counter monograph drugsSeptember 16, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.